stella
beta
Response Adaptive Radiotherapy Following Immunotherapy-based Induction for Non-HPV Related HNSCC — Stella
Recruiting
Back to Head and Neck Cancer trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
China
National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, CAMS & PUMC, Beijing
View full record on ClinicalTrials.gov